The Dupixent Lawsuits Are Now in a Federal MDL — Here’s What That Means for Your Claim

On June 4, 2026, a federal panel combined all of the Dupixent lawsuits into one case, in front of one judge: Judge Zahid N. Quraishi, in the U.S. District Court for the District of New Jersey. The case is called MDL No. 3180. You can read the court’s order here. This matters to you if you or a family member took Dupixent and were later diagnosed with a T-cell lymphoma like CTCL….
By: Morris James LLP